| Authors: |
Rosenzwajg M; Biotherapy Clinical Investigation Center (CIC-BTi) and Inflammation-Immunopathology-Immunotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR_S 959, Paris, France., Gherasim A; Centre de recherche clinique ALYATEC, Strasbourg, France., Dietsch F; Centre de recherche clinique ALYATEC, Strasbourg, France., Beck M; Centre de recherche clinique ALYATEC, Strasbourg, France., Domis N; Centre de recherche clinique ALYATEC, Strasbourg, France., Lorenzon R; Biotherapy Clinical Investigation Center (CIC-BTi) and Inflammation-Immunopathology-Immunotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR_S 959, Paris, France., Chantran Y; Immunology Department, Saint Antoine Hospital, AP-HP, Paris, France., Bellier B; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR_S 959, Paris, France., Vicaut E; Unité de recherche clinique, Saint Louis/Lariboisière Hospitals, AP-HP, and Université Paris 7, Paris, France., Soria A; Dermatology and Allergy Department, Tenon Hospital, AP-HP, Paris., de Blay F; Centre de recherche clinique ALYATEC, Strasbourg, France., Klatzmann D; Biotherapy Clinical Investigation Center (CIC-BTi) and Inflammation-Immunopathology-Immunotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Immunology-Immunopathology-Immunotherapy, Sorbonne Université, INSERM, UMR_S 959, Paris, France. Electronic address: david.klatzmann@sorbonne-universite.fr. |
